Delivery Order SPE2DB22D2007-SPE2DB23FJ4HX
Award Date 7/21/23
Potential Completion Date 8/11/23
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania from August 9-30, 2023, this order is funded through DLA's portfolio of contracts for pharmaceuticals and medical supplies supporting the Department of Defense. As a top 10 federal contractor, Amerisourcebergen will deliver the products from its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,793.70 delivery order for Xeomin 100 Unit Vials, a botulinum toxin product used for medical purposes. This competitive award, issued on August 25, 2025, carries an ultimate completion date of September 16, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under the company's...
- The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical purposes. Performance will take place in Conshohocken, Pennsylvania over a four week period concluding in mid-September 2023. The prime contractor, Amerisourcebergen Drug Corporation, will supply the botulinum toxin products to the DLA, the Department of Defense's logistics combat support agency, in support of the...
- The Defense Logistics Agency Troop Support Medical awarded a $22,018 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The place of performance is Conshohocken, Pennsylvania. The order period is from July 12, 2023 through August 2, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will deliver botulinum toxin type A to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $9,436 to Amerisourcebergen Drug Corporation to provide 200 units of Xeomin, a botulinum toxin used for medical treatments. As the prime contractor, Amerisourcebergen will deliver the products to a facility in Conshohocken, Pennsylvania by August 30th, fulfilling requirements under an existing indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were...
- The Defense Logistics Agency awarded a $13,106 delivery order to Amerisourcebergen Drug Corp for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed under contract number 4562256535, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by October 12, 2023. The firm fixed price order was awarded through an existing DLA contract vehicle and no set aside designation was specified. As a leading provider of medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,174.80 for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by November 17, 2025. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Troop Support Medical awarded a $44,036 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin, a botulinum toxin type A. The contract has a period of performance from August 22, 2023 through September 13, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania. The Defense Logistics Agency manages the global supply chain for the United States Department of Defense, procuring a wide...
- The Defense Logistics Agency awarded a $8,550 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 vials of Xeomin. The contract has a period of performance from July 13, 2023 through August 3, 2023 and will be performed in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will supply the botulinum toxin Type A injection to the Defense Logistics Agency in support of its medical materiel procurement programs. No...
- The Defense Logistics Agency awarded a $23,467.08 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This competitively awarded, firm fixed-price contract has a completion date of November 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB23FJ4HXDelivery Order
The Defense Logistics Agency awarded a $10,484.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania from July 21, 2023 through August 11, 2023, this order is funded through the DLA in support of Department of Defense requirements. As a top 10 federal contractor, Amerisourcebergen will deliver the contracted pharmaceutical products without involving major subcontractors. The brief period of performance indicates an urgent clinical need within DOD treatment facilities.
Generated 12/20/23, 1:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 7/21/23 |